Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-07-30

Clinical Trial Update: Randomized Controlled Single-blind Non-inferiority Trial Comparing an Offer of Initial Virtual Visit and Usual Care [NA]

View source ↗

Summary

A randomized single-blind non-inferiority trial comparing an initial virtual visit to usual care for musculoskeletal diseases has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Texas at Austin | Conditions: Musculoskeletal Diseases | NA | Status: WITHDRAWN